Evidence-Based Complementary and Alternative Medicine / 2012 / Article / Tab 3

Research Article

Liuwei Dihuang Lowers Body Weight and Improves Insulin and Leptin Sensitivity in Obese Rats

Table 3

Serum liver enzyme profile in obese rats in response to LWDH treatment (mean values with their standard errors, ).

Control groupsLWDH-treated groups
OROPT1AT1BT1C
MeanSEMeanSEMeanSEMeanSEMeanSE

AST (U/L)197.5425.14178.799.67180.4612.09187.2513.53199.4612.77
ALT (U/L)38.001.8346.041.9544.881.5141.881.1644.452.06
ALP (U/L)168.2113.15295.751.69269.386.16271.2915.58252.63*11.68
GGT (U/L)8.710.149.120.258.830.339.250.238.770.42

LWDH: Liuwei Dihuang; OR: obesity-resistant normal control group; OP: obesity-prone positive control group; T1A: 500 mg/kg/d LWDH group; T1B: 1500 mg/kg/d LWDH group; T1C: 3500 mg/kg/d LWDH group.
*Mean values within a row were significantly different from OP (pair-wise comparisons using the least squares means test; ).
The change in serum liver enzyme profiles in obese rats treated with total daily dosages of 500, 1500, or 3500 mg/kg BW LWDH is given.

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.